Package 0002-1717-56

{"route": ["ORAL"], "spl_id": "1ece6e73-2242-434e-b297-7ccf07a54c1e", "openfda": {"nui": ["N0000175582", "N0000000145", "N0000185503", "N0000190113"], "unii": ["9CXQ3PF69U"], "rxcui": ["2725917", "2725923"], "spl_set_id": ["5bc172e4-e8a2-441a-be52-279a7f890196"], "pharm_class_epc": ["Estrogen Receptor Antagonist [EPC]"], "pharm_class_moa": ["Estrogen Receptor Antagonists [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "28 TABLET, FILM COATED in 1 BOTTLE (0002-1717-28)", "package_ndc": "0002-1717-28", "marketing_start_date": "20251016"}, {"sample": false, "description": "56 TABLET, FILM COATED in 1 BOTTLE (0002-1717-56)", "package_ndc": "0002-1717-56", "marketing_start_date": "20251015"}, {"sample": true, "description": "56 TABLET, FILM COATED in 1 BOTTLE (0002-1717-61)", "package_ndc": "0002-1717-61", "marketing_start_date": "20251113"}], "brand_name": "Inluriyo", "product_id": "0002-1717_1ece6e73-2242-434e-b297-7ccf07a54c1e", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Estrogen Receptor Antagonist [EPC]", "Estrogen Receptor Antagonists [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "0002-1717", "generic_name": "imlunestrant", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Inluriyo", "active_ingredients": [{"name": "IMLUNESTRANT", "strength": "200 mg/1"}], "application_number": "NDA218881", "marketing_category": "NDA", "marketing_start_date": "20250925", "listing_expiration_date": "20271231"}